These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 9811335)
1. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Fischer AH; Bond JA; Taysavang P; Battles OE; Wynford-Thomas D Am J Pathol; 1998 Nov; 153(5):1443-50. PubMed ID: 9811335 [TBL] [Abstract][Full Text] [Related]
2. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638 [TBL] [Abstract][Full Text] [Related]
3. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913 [TBL] [Abstract][Full Text] [Related]
4. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089 [TBL] [Abstract][Full Text] [Related]
5. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225 [TBL] [Abstract][Full Text] [Related]
6. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822 [TBL] [Abstract][Full Text] [Related]
7. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145 [TBL] [Abstract][Full Text] [Related]
8. RET/PTC rearrangement in thyroid tumors. Nikiforov YE Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746 [TBL] [Abstract][Full Text] [Related]
9. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Zou M; Shi Y; Farid NR Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421 [TBL] [Abstract][Full Text] [Related]
10. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781 [TBL] [Abstract][Full Text] [Related]
11. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Santoro M; Chiappetta G; Cerrato A; Salvatore D; Zhang L; Manzo G; Picone A; Portella G; Santelli G; Vecchio G; Fusco A Oncogene; 1996 Apr; 12(8):1821-6. PubMed ID: 8622903 [TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
13. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191 [TBL] [Abstract][Full Text] [Related]
14. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population. Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322 [TBL] [Abstract][Full Text] [Related]
15. Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma. Finn SP; Smyth P; O'Leary J; Sweeney EC; Sheils O J Clin Endocrinol Metab; 2003 Feb; 88(2):938-41. PubMed ID: 12574236 [TBL] [Abstract][Full Text] [Related]
16. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation. Cetta F; Gori M; Montalto G; Zuckermann M; Toti P J Clin Endocrinol Metab; 2001 Mar; 86(3):1429. PubMed ID: 11238550 [No Abstract] [Full Text] [Related]
17. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
18. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036 [TBL] [Abstract][Full Text] [Related]
19. [Rearrangement of the RET gene in papillary thyroid carcinoma]. Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064 [TBL] [Abstract][Full Text] [Related]
20. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]